Perspective Interest Debt Per Share from 2010 to 2025

CATX Stock   2.78  0.17  6.51%   
Perspective Therapeutics Interest Debt Per Share yearly trend continues to be fairly stable with very little volatility. Interest Debt Per Share is likely to outpace its year average in 2025. During the period from 2010 to 2025, Perspective Therapeutics Interest Debt Per Share regression line of annual values had r-squared of  0.16 and arithmetic mean of  0.51. View All Fundamentals
 
Interest Debt Per Share  
First Reported
2010-12-31
Previous Quarter
0.11
Current Value
0.11
Quarterly Volatility
1.92686249
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Perspective Therapeutics financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Perspective Therapeutics' main balance sheet or income statement drivers, such as Depreciation And Amortization of 1.2 M, Total Revenue of 1.6 M or Gross Profit of 1.3 M, as well as many indicators such as Price To Sales Ratio of 54.85, Dividend Yield of 0.0 or PTB Ratio of 1.22. Perspective financial statements analysis is a perfect complement when working with Perspective Therapeutics Valuation or Volatility modules.
  
Check out the analysis of Perspective Therapeutics Correlation against competitors.
For more information on how to buy Perspective Stock please use our How to Invest in Perspective Therapeutics guide.

Latest Perspective Therapeutics' Interest Debt Per Share Growth Pattern

Below is the plot of the Interest Debt Per Share of Perspective Therapeutics over the last few years. It is Perspective Therapeutics' Interest Debt Per Share historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Perspective Therapeutics' overall financial position and show how it may be relating to other accounts over time.
Interest Debt Per Share10 Years Trend
Slightly volatile
   Interest Debt Per Share   
       Timeline  

Perspective Interest Debt Per Share Regression Statistics

Arithmetic Mean0.51
Geometric Mean0
Coefficient Of Variation374.66
Mean Deviation0.90
Median0.01
Standard Deviation1.93
Sample Variance3.71
Range7.7382
R-Value(0.40)
Mean Square Error3.33
R-Squared0.16
Significance0.12
Slope(0.16)
Total Sum of Squares55.69

Perspective Interest Debt Per Share History

2024 0.11
2022 0.0985
2021 0.004529
2020 0.007473
2016 0.0149
2015 1.7E-5
2014 4.0E-5

About Perspective Therapeutics Financial Statements

Perspective Therapeutics investors use historical fundamental indicators, such as Perspective Therapeutics' Interest Debt Per Share, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Perspective Therapeutics. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Interest Debt Per Share 0.10  0.11 

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for Perspective Stock Analysis

When running Perspective Therapeutics' price analysis, check to measure Perspective Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Perspective Therapeutics is operating at the current time. Most of Perspective Therapeutics' value examination focuses on studying past and present price action to predict the probability of Perspective Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Perspective Therapeutics' price. Additionally, you may evaluate how the addition of Perspective Therapeutics to your portfolios can decrease your overall portfolio volatility.